ORAMED PHARMACEUTICALS INC. Quarterly Operating Income (Loss) in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2010 to Q3 2024.
  • Oramed Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.09M, a 6.78% decline year-over-year.
  • Oramed Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$13.1M, a 46.1% increase year-over-year.
  • Oramed Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$15.8M, a 61.2% increase from 2022.
  • Oramed Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$40.6M, a 67.6% decline from 2021.
  • Oramed Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$24.2M, a 106% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$13.1M -$3.09M -$196K -6.78% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$12.9M -$3.14M +$656K +17.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$13.5M -$2.96M +$2.25M +43.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$15.8M -$3.88M +$8.45M +68.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 -$24.2M -$2.89M +$5.3M +64.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$29.5M -$3.79M +$7.63M +66.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$37.1M -$5.21M +$6.04M +53.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$43.2M -$12.3M $0 0% Sep 1, 2022 Dec 31, 2022 10-K 2023-03-06
Q3 2022 -$43.2M -$8.19M -$704K -9.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$42.5M -$11.4M -$6.97M -157% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$35.5M -$11.3M -$4.65M -70.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$30.9M -$12.3M -$4.77M -63% Sep 1, 2021 Dec 31, 2021 10-QT 2022-03-30
Q3 2021 -$26.1M -$7.49M -$4.47M -148% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$21.6M -$4.45M -$2.18M -95.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$19.5M -$6.6M -$2.57M -63.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$16.9M -$7.56M -$5.13M -211% Sep 1, 2020 Dec 31, 2020 10-QT 2022-03-30
Q3 2020 -$11.8M -$3.02M -$672K -28.7% Jun 1, 2020 Aug 31, 2020 10-K 2021-11-24
Q2 2020 -$11.1M -$2.27M +$1.8M +44.2% Mar 1, 2020 May 31, 2020 10-Q 2021-07-14
Q1 2020 -$12.9M -$4.04M -$469K -13.1% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-13
Q4 2019 -$12.4M -$2.43M +$2.21M +47.7% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q3 2019 -$14.6M -$2.35M +$805K +25.6% Jun 1, 2019 Aug 31, 2019 10-K 2020-11-24
Q2 2019 -$15.4M -$4.08M +$456K +10.1% Mar 1, 2019 May 31, 2019 10-Q 2020-07-07
Q1 2019 -$15.9M -$3.57M -$457K -14.7% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-06
Q4 2018 -$15.4M -$4.64M -$1.91M -69.8% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
Q3 2018 -$13.5M -$3.15M -$297K -10.4% Jun 1, 2018 Aug 31, 2018 10-K 2019-11-27
Q2 2018 -$13.2M -$4.53M -$2.38M -110% Mar 1, 2018 May 31, 2018 10-Q 2019-07-10
Q1 2018 -$10.9M -$3.11M +$254K +7.55% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-10
Q4 2017 -$11.1M -$2.73M -$334K -13.9% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-14
Q3 2017 -$10.8M -$2.85M +$9.8M +77.5% Jun 1, 2017 Aug 31, 2017 10-K 2019-11-27
Q2 2017 -$20.6M -$2.16M -$4.27M -202% Mar 1, 2017 May 31, 2017 10-Q 2018-07-12
Q1 2017 -$16.3M -$3.37M -$1.45M -76% Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-09
Q4 2016 -$14.9M -$2.4M -$4.85M -198% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-11
Q3 2016 -$10M -$12.7M -$10.5M -482% Jun 1, 2016 Aug 31, 2016 10-K 2018-11-28
Q2 2016 $474K $2.11M +$3.74M Mar 1, 2016 May 31, 2016 10-Q 2017-07-06
Q1 2016 -$3.27M -$1.91M -$238K -14.2% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-05
Q4 2015 -$3.03M $2.45M +$4.35M Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-11
Q3 2015 -$7.38M -$2.17M +$3.28M +60.2% Jun 1, 2015 Aug 31, 2015 10-K 2017-11-29
Q2 2015 -$10.7M -$1.63M -$3.54M -186% Mar 1, 2015 May 31, 2015 10-Q 2016-07-06
Q1 2015 -$7.13M -$1.67M -$488K -41.1% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-06
Q4 2014 -$6.64M -$1.9M -$734K -62.8% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-13
Q3 2014 -$5.91M -$5.46M -$13.1M -171% Jun 1, 2014 Aug 31, 2014 10-K 2016-11-25
Q2 2014 $7.18M $1.9M +$3.24M Mar 1, 2014 May 31, 2014 10-Q 2015-07-01
Q1 2014 $3.94M -$1.19M +$73.8K +5.86% Dec 1, 2013 Feb 28, 2014 10-Q 2015-04-03
Q4 2013 $3.87M -$1.17M -$436K -59.6% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-08
Q3 2013 $4.3M $7.63M +$8.57M Jun 1, 2013 Aug 31, 2013 10-K 2015-11-25
Q2 2013 -$4.26M -$1.33M -$794K -147% Mar 1, 2013 May 31, 2013 10-Q 2014-07-14
Q1 2013 -$3.47M -$1.26M -$319K -34% Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-10
Q4 2012 -$3.15M -$732K -$266K -57.1% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q3 2012 -$2.88M -$937K -$342K -57.5% Jun 1, 2012 Aug 31, 2012 10-K 2014-11-14
Q2 2012 -$2.54M -$540K +$51.1K +8.63% Mar 1, 2012 May 31, 2012 10-Q 2013-07-17
Q1 2012 -$2.59M -$940K -$293K -45.3% Dec 1, 2011 Feb 29, 2012 10-Q 2013-04-11
Q4 2011 -$2.3M -$466K +$136K +22.6% Sep 1, 2011 Nov 30, 2011 10-Q 2012-12-26
Q3 2011 -$2.44M -$595K Jun 1, 2011 Aug 31, 2011 10-K 2012-12-12
Q2 2011 -$591K Mar 1, 2011 May 31, 2011 10-Q 2012-07-12
Q1 2011 -$647K Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-04
Q4 2010 -$602K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.